Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Open Access
- 8 February 2024
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (2) , 251
Abstract
Immunosuppressive elements within the tumor microenvironment are the primary drivers of tumorigenesis and malignant advancement. The presence, as well as the crosstalk between myeloid-derived suppressor cells (MDSCs), osteosarcoma-associated macrophages (OS-Ms), regulatory T cells (Tregs), and endothelial cells (ECs) with osteosarcoma cells cause the poor prognosis of OS. In addition, the consequent immunosuppressive factors favor the loss of treatment potential. Nanoparticles offer a means to dynamically and locally manipulate immuno-nanoparticles, which present a promising strategy for transforming OS-TME. Additionally, chimeric antigen receptor (CAR) technology is effective in combating OS. This review summarizes the essential mechanisms of immunosuppressive cells in the OS-TME and the current immune-associated strategies. The last part highlights the limitations of existing therapies and offers insights into future research directions.Keywords
This publication has 211 references indexed in Scilit:
- Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axisNature, 2013
- PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structuresFrontiers in Immunology, 2012
- Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of LeukemiaACS Nano, 2011
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptorBlood, 2010
- Hypoxia-Inducible Factors as Essential Regulators of Inflammation2010
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen ExpressionMolecular Therapy, 2009
- The Role of Regulatory T Cells in CancerImmune Network, 2009
- Zoledronic Acid Activates the DNA S-Phase Checkpoint and Induces Osteosarcoma Cell Death Characterized by Apoptosis-Inducing Factor and Endonuclease-G Translocation Independently of p53 and Retinoblastoma StatusMolecular Pharmacology, 2007
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- The origin and function of tumor-associated macrophagesImmunology Today, 1992